Search
Oct 7
George Church on founder led companies, synthetic biology technologies, the future, and more
Dan Mandell, Co-Founder and CEO of GRO Biosciences, interviews professor Church about the Genomically Recoded Organisms (GRO) platform...
Jul 19
GRO Biosciences announced a $60 million series B today to help advance its pipeline that is rooted in adding non-standard amino acid (NSAA) chemistries to therapies.
Co-founder and CEO Dan Mandell discusses the company’s approach, and describes how this will allow GRObio to advance its lead program for...
Jul 13, 2023
GRO Biosciences demonstrates how automated technologies enable its scientists to test wide spaces.
GRO Biosciences CEO Dan Mandell explains how new technologies enable small companies to test new ideas widely.
.png){kind=logo}
